The SHP2 gain-of-function (GOF) or loss-of-function (LOF) mutation can cause multiple genetic diseases characterized by bone developmental malformations, such as Noonan syndrome (NS), LEOPARD syndrome and metachondromatosis [7]. This evidence concerns the gene PTPN11 and Netherton syndrome.